Annual EBIT
-$49.49 M
+$2.81 M+5.37%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual earnings before interest & taxes is -$49.49 million, with the most recent change of +$2.81 million (+5.37%) on December 31, 2023.
- During the last 3 years, CUE annual EBIT has fallen by -$4.45 million (-9.87%).
- CUE annual EBIT is now -2465.87% below its all-time high of -$1.93 million, reached on December 31, 2015.
Performance
CUE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$8.47 M
+$1.48 M+14.91%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly earnings before interest & taxes is -$8.47 million, with the most recent change of +$1.48 million (+14.91%) on September 30, 2024.
- Over the past year, CUE quarterly EBIT has increased by +$1.48 million (+14.91%).
- CUE quarterly EBIT is now -318.54% below its all-time high of -$2.02 million, reached on September 30, 2016.
Performance
CUE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$43.46 M
+$2.25 M+4.92%
September 30, 2024
Summary
- As of February 20, 2025, CUE TTM earnings before interest & taxes is -$43.46 million, with the most recent change of +$2.25 million (+4.92%) on September 30, 2024.
- Over the past year, CUE TTM EBIT has increased by +$2.25 million (+4.92%).
- CUE TTM EBIT is now -2047.07% below its all-time high of -$2.02 million, reached on September 30, 2016.
Performance
CUE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CUE EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.4% | +14.9% | +4.9% |
| 3 y3 years | -9.9% | +40.5% | +16.9% |
| 5 y5 years | -27.9% | +40.5% | +16.9% |
CUE EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -13.3% | +5.4% | -7.4% | +40.5% | at high | +16.9% |
| 5 y | 5-year | -34.6% | +5.4% | -7.4% | +40.5% | -17.9% | +16.9% |
| alltime | all time | -2465.9% | +5.4% | -318.5% | +40.5% | -2047.1% | +16.9% |
Cue Biopharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.47 M(-14.9%) | -$43.46 M(-4.9%) |
| Jun 2024 | - | -$9.96 M(-17.8%) | -$45.71 M(-6.2%) |
| Mar 2024 | - | -$12.11 M(-6.4%) | -$48.70 M(-1.3%) |
| Dec 2023 | -$49.49 M(-5.4%) | -$12.93 M(+20.6%) | -$49.34 M(-2.6%) |
| Sep 2023 | - | -$10.72 M(-17.2%) | -$50.65 M(-0.2%) |
| Jun 2023 | - | -$12.95 M(+1.7%) | -$50.76 M(-0.1%) |
| Mar 2023 | - | -$12.74 M(-10.5%) | -$50.81 M(-2.9%) |
| Dec 2022 | -$52.30 M(+19.8%) | -$14.23 M(+31.4%) | -$52.30 M(+13.8%) |
| Sep 2022 | - | -$10.83 M(-16.7%) | -$45.95 M(-4.5%) |
| Jun 2022 | - | -$13.00 M(-8.6%) | -$48.11 M(+6.0%) |
| Mar 2022 | - | -$14.23 M(+80.4%) | -$45.39 M(+4.0%) |
| Dec 2021 | -$43.67 M(-3.1%) | -$7.89 M(-39.3%) | -$43.67 M(-6.6%) |
| Sep 2021 | - | -$12.99 M(+26.4%) | -$46.75 M(+6.5%) |
| Jun 2021 | - | -$10.28 M(-17.8%) | -$43.89 M(-1.5%) |
| Mar 2021 | - | -$12.51 M(+13.9%) | -$44.55 M(-1.1%) |
| Dec 2020 | -$45.04 M | -$10.97 M(+8.3%) | -$45.04 M(+4.5%) |
| Sep 2020 | - | -$10.13 M(-7.4%) | -$43.08 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$10.94 M(-15.8%) | -$40.05 M(+4.2%) |
| Mar 2020 | - | -$12.99 M(+44.1%) | -$38.43 M(+4.3%) |
| Dec 2019 | -$36.77 M(-5.0%) | -$9.02 M(+27.1%) | -$36.86 M(-5.0%) |
| Sep 2019 | - | -$7.09 M(-23.9%) | -$38.81 M(-12.7%) |
| Jun 2019 | - | -$9.32 M(-18.4%) | -$44.48 M(+4.3%) |
| Mar 2019 | - | -$11.43 M(+4.2%) | -$42.62 M(+10.1%) |
| Dec 2018 | -$38.70 M(+66.6%) | -$10.97 M(-14.0%) | -$38.72 M(+1.4%) |
| Sep 2018 | - | -$12.76 M(+70.8%) | -$38.19 M(+25.4%) |
| Jun 2018 | - | -$7.47 M(-0.7%) | -$30.46 M(+11.2%) |
| Mar 2018 | - | -$7.52 M(-27.9%) | -$27.41 M(+18.0%) |
| Dec 2017 | -$23.23 M(+203.4%) | -$10.44 M(+107.5%) | -$23.23 M(+48.6%) |
| Sep 2017 | - | -$5.03 M(+14.0%) | -$15.64 M(+23.8%) |
| Jun 2017 | - | -$4.41 M(+31.7%) | -$12.63 M(+53.7%) |
| Mar 2017 | - | -$3.35 M(+17.9%) | -$8.22 M(+68.8%) |
| Dec 2016 | -$7.66 M(+297.1%) | -$2.84 M(+40.4%) | -$4.87 M(+140.4%) |
| Sep 2016 | - | -$2.02 M | -$2.02 M |
| Dec 2015 | -$1.93 M | - | - |
FAQ
- What is Cue Biopharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for Cue Biopharma?
- What is Cue Biopharma annual EBIT year-on-year change?
- What is Cue Biopharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Cue Biopharma?
- What is Cue Biopharma quarterly EBIT year-on-year change?
- What is Cue Biopharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Cue Biopharma?
- What is Cue Biopharma TTM EBIT year-on-year change?
What is Cue Biopharma annual earnings before interest & taxes?
The current annual EBIT of CUE is -$49.49 M
What is the all time high annual EBIT for Cue Biopharma?
Cue Biopharma all-time high annual earnings before interest & taxes is -$1.93 M
What is Cue Biopharma annual EBIT year-on-year change?
Over the past year, CUE annual earnings before interest & taxes has changed by +$2.81 M (+5.37%)
What is Cue Biopharma quarterly earnings before interest & taxes?
The current quarterly EBIT of CUE is -$8.47 M
What is the all time high quarterly EBIT for Cue Biopharma?
Cue Biopharma all-time high quarterly earnings before interest & taxes is -$2.02 M
What is Cue Biopharma quarterly EBIT year-on-year change?
Over the past year, CUE quarterly earnings before interest & taxes has changed by +$1.48 M (+14.91%)
What is Cue Biopharma TTM earnings before interest & taxes?
The current TTM EBIT of CUE is -$43.46 M
What is the all time high TTM EBIT for Cue Biopharma?
Cue Biopharma all-time high TTM earnings before interest & taxes is -$2.02 M
What is Cue Biopharma TTM EBIT year-on-year change?
Over the past year, CUE TTM earnings before interest & taxes has changed by +$2.25 M (+4.92%)